Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double Diabetes”

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07558525
What this trial is testing

Evaluation of Chiglitazar Sodium With Lifestyle Intervention for Reversing Prediabetes

Who this might be right for
Prediabetes
Second Xiangya Hospital of Central South University 472
Early research (Phase 1)Ended earlyNCT00707590
What this trial is testing

Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Bristol-Myers Squibb 120
Large-scale testing (Phase 3)Study completedNCT01572740
What this trial is testing

Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 257
Post-approval studies (Phase 4)Study completedNCT03962296
What this trial is testing

A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon®

Who this might be right for
Diabetic Retinopathy
Hanyang University 153
Testing effectiveness (Phase 2)Study completedNCT04432090
What this trial is testing

GPR119 Agonist for Hypoglycemia in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
AdventHealth Translational Research Institute 110
Early research (Phase 1)Study completedNCT01789788
What this trial is testing

A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT06812988
What this trial is testing

Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule

Who this might be right for
Type 1 Diabetes Mellitus
Sanofi 84
Large-scale testing (Phase 3)Study completedNCT01189890
What this trial is testing

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 480
Large-scale testing (Phase 3)Study completedNCT01682759
What this trial is testing

The Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 751
Large-scale testing (Phase 3)Ended earlyNCT01609582
What this trial is testing

Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease

Who this might be right for
Type 2 DiabetesCardiovascular Disease
Takeda 3,207
Post-approval studies (Phase 4)UnknownNCT01001962
What this trial is testing

Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics

Who this might be right for
HypertensionType II Diabetes
Aristotle University Of Thessaloniki 1,054
Testing effectiveness (Phase 2)WithdrawnNCT03794973
What this trial is testing

Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)

Who this might be right for
Diabetes Mellitus, Type 1
Tolerion, Inc.
Large-scale testing (Phase 3)Study completedNCT01081834
What this trial is testing

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 678
Testing effectiveness (Phase 2)Study completedNCT00650806
What this trial is testing

The Safety and Effectiveness of Canagliflozin (JNJ-28431754) in Promoting Weight Loss in Overweight and Obese Patients Who do Not Have Diabetes

Who this might be right for
Obesity
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 376
Not applicableEnded earlyNCT00871312
What this trial is testing

Evaluation of Topical Wound Oxygen (two2) Therapy

Who this might be right for
Diabetic Ulcer
AOTI Ltd. 21
Testing effectiveness (Phase 2)Study completedNCT02653599
What this trial is testing

Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
vTv Therapeutics 174
Large-scale testing (Phase 3)Study completedNCT01594333
What this trial is testing

Cardiovascular Inflammation Reduction Trial

Who this might be right for
Cardiovascular Disease
Brigham and Women's Hospital 4,786
Not applicableStudy completedNCT04591639
What this trial is testing

The DAPA-MEMRI Trial

Who this might be right for
Heart FailureDiabetic Cardiomyopathies
University of Edinburgh 81
Large-scale testing (Phase 3)Study completedNCT01023581
What this trial is testing

Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 784
Testing effectiveness (Phase 2)Study completedNCT02205528
What this trial is testing

Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Who this might be right for
DiabetesDiabetes Mellitus Type 2
Novo Nordisk A/S 108
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation